We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

45 hedge funds and large institutions have $50.4M invested in InVivo Therapeutics Holdings Corp in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

13% more capital invested

Capital invested by funds: $44.5M → $50.4M (+$5.97M)

2% more funds holding

Funds holding: 44 → 45 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

64% less call options, than puts

Call options by funds: $255K | Put options by funds: $712K

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
8
Reduced
5
Closed
3
Calls
$255K
Puts
$712K
Net Calls
-$457K
Net Calls Change
-$1.53M

Top Buyers

Rank Fund Capital Flow
1
GC
Guggenheim Capital
Illinois
+$1.12M
2
ICM
IMS Capital Management
Oregon
+$749K
3
TI
Turner Investments
Pennsylvania
+$624K
4
BFA
BlackRock Fund Advisors
California
+$374K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$374K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$3.87M
2
Goldman Sachs
Goldman Sachs
New York
-$873K
3
CS
Credit Suisse
Switzerland
-$125K
4
CG
Cutler Group
California
-$125K
5
LPL Financial
LPL Financial
California
-$125K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$264K – – –
Millennium Management
27
Millennium Management
New York
$218K – – –
CDH
28
Charles D. Hyman
$204K – – –
MLICM
29
Metropolitan Life Insurance Company (MetLife)
New York
$183K – – –
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$165K – – –
Manulife (Manufacturers Life Insurance)
31
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$157K – – –
NFA
32
Nationwide Fund Advisors
Ohio
$157K – – –
HighTower Advisors
33
HighTower Advisors
Illinois
$144K – – –
LPL Financial
34
LPL Financial
California
$133K -$125K -1 -50%
Cambridge Investment Research Advisors
35
Cambridge Investment Research Advisors
Iowa
$132K – – –
State Board of Administration of Florida Retirement System
36
State Board of Administration of Florida Retirement System
Florida
$129K – – –
AIG
37
American International Group
New York
$126K – – –
BA
38
BlackRock Advisors
Delaware
$114K – – –
ITIM
39
Indiana Trust & Investment Management
Indiana
$90K – – –
CS
40
Credit Suisse
Switzerland
$86K -$125K -1 -50%
Bank of America
41
Bank of America
North Carolina
$83K +$125K +1 New
HKIM
42
Hayek Kallen Investment Management
Alabama
$82K – – –
Wells Fargo
43
Wells Fargo
California
$77K +$125K +1 New
Deutsche Bank
44
Deutsche Bank
Germany
$52K – – –
AG
45
Advisor Group
Arizona
$41K – – –
Legal & General Group
46
Legal & General Group
United Kingdom
$39K – – –
Creative Planning
47
Creative Planning
Kansas
$33K – – –
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$27K – – –
MWP
49
MYCIO Wealth Partners
Pennsylvania
$27K – – –
Barclays
50
Barclays
United Kingdom
$23K – – –
1
2
3

NVIV Hedge Fund Activity: Q3 2016 in Review

45 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q3 2016, worth a combined $50.4M — up 13% from $44.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NVIV positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Guggenheim Capital, opening a new position worth an estimated $1.12M. The largest seller was Sabby Management, exiting entirely with an estimated $3.87M sold.

  • 45 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q3 2016, up from 44 in Q2 2016.
  • Funds reported $50.4M of InVivo Therapeutics Holdings Corp stock for Q3 2016, up 13% quarter-over-quarter.
  • 4 funds opened new InVivo Therapeutics Holdings Corp positions in Q3 2016 and 3 closed out, a net change of +1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q3 2016 was Guggenheim Capital, an estimated $1.12M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q3 2016 was Sabby Management, an estimated $3.87M sold.

Based on aggregated 13F filings for Q3 2016.